The estimated Net Worth of Donald P. Lehr is at least $2.13 million dollars as of 5 April 2024. Mr. Lehr owns over 164,285 units of Precigen Inc stock worth over $575,405 and over the last 11 years he sold PGEN stock worth over $0. In addition, he makes $1,556,740 as Chief Legal Officer at Precigen Inc.
Donald has made over 29 trades of the Precigen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 164,285 units of PGEN stock worth $159,356 on 5 April 2024.
The largest trade he's ever made was exercising 175,000 units of Precigen Inc stock on 15 May 2020 worth over $169,750. On average, Donald trades about 15,321 units every 70 days since 2013. As of 5 April 2024 he still owns at least 593,201 units of Precigen Inc stock.
You can see the complete history of Mr. Lehr stock trades at the bottom of the page.
Donald P. Lehr is the Chief Legal Officer of Intrexon Corporation. Mr. Lehr has served as our Chief Legal Officer since 2011. From 2009 to 2011 he served as our Associate General Counsel. Mr. Lehr has broad experience in the areas of corporate, securities, and general business law. Prior to joining us, he practiced law with the law firm of Hogan Lovells US LLP (formerly Hogan & Hartson, LLP) in Baltimore, Maryland from 2002 to 2009. While at Hogan Lovells, his practice included the representation of privately and publicly held corporations across many industries, including biotechnology, pharmaceuticals, health care, software, technology, and manufacturing. Prior to his time at Hogan Lovells, Mr. Lehr served as a judicial clerk for the Honorable Irma S. Raker of the Court of Appeals of Maryland. Mr. Lehr received a B.A. from Swarthmore College and received a J.D. from the University of Maryland School of Law.
As the Chief Legal Officer of Precigen Inc, the total compensation of Donald Lehr at Precigen Inc is $1,556,740. There are 2 executives at Precigen Inc getting paid more, with Randal Kirk having the highest compensation of $2,067,620.
Donald Lehr is 45, he's been the Chief Legal Officer of Precigen Inc since 2011. There are 18 older and no younger executives at Precigen Inc. The oldest executive at Precigen Inc is Robert Shapiro, 81, who is the Lead Independent Director.
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares et Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Precigen Inc executives and other stock owners filed with the SEC include: